NEKTAR THERAPEUTICS revenue breakdown overview

NEKTAR THERAPEUTICS revenue for the last year amounted to 81.65 M EUR, the most of which — 81.65 M EUR — came from its highest performing source at the moment, Novel Drug Candidates, the year earlier bringing 86.01 M EUR. The greatest contribution to the revenue figure was made by Rest of World — last year it brought NEKTAR THERAPEUTICS 71.25 M EUR, and the year before that — 76.82 M EUR.